Price Chart


Price Chart

Profile

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.
URL http://www.circassia.co.uk
Investor Relations URL N/A
HQ State/Province Oxfordshire
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release Sep. 29, 2026 (est.)
Last Earnings Release Mar. 24, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 22, 2026

Profile

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.
URL http://www.circassia.co.uk
Investor Relations URL N/A
HQ State/Province Oxfordshire
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release Sep. 29, 2026 (est.)
Last Earnings Release Mar. 24, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 22, 2026